AJCC 8th edition (2017) anatomic stage from T / N / M. Biomarkers are recorded but the prognostic stage is not computed here.
T — primary tumour
Tis — carcinoma in situ (DCIS) or Paget disease without an invasive tumour
T0 — no evidence of primary tumour
T1mi — microinvasion ≤ 1 mm
T4a — extension to the chest wall (not pectoralis alone)
T4b — skin oedema (peau d'orange), ulceration, or satellite skin nodules
T4d — inflammatory carcinoma
N — regional lymph nodes
N0 — no regional lymph node metastasis
N1mi — micrometastases (> 0.2 mm or > 200 cells, none > 2 mm)
N1 — 1–3 axillary nodes, and/or internal mammary nodes detected only by sentinel biopsy
N2 — 4–9 axillary nodes, or clinically detected internal mammary nodes without axillary involvement
N3 — ≥ 10 axillary nodes, or infraclavicular/supraclavicular nodes, or extensive internal mammary + axillary disease
Evidence
[1] Original publication
Giuliano AE, Connolly JL, Edge SB, et al. Breast cancer — major changes in the AJCC eighth-edition cancer staging manual. Retained the anatomic (TNM) stage and added a prognostic stage that incorporates histological grade and ER, PR and HER2 status; biomarkers can move the prognostic stage up or down relative to the anatomic stage.
CA: A Cancer Journal for Clinicians, 2017
[2] Guideline
Amin MB, Edge SB, Greene FL, et al., eds. AJCC Cancer Staging Manual, 8th edition (print manual, no PubMed record).
Springer, 2017
[3] Note on this tool
Only the flagship prognostic-stage rules are implemented here; combinations not covered fall back to the anatomic stage. Confirm the assigned stage against the full AJCC prognostic-stage table.
Last reviewed: 2026-10
Report an error in this calculator